FDA okays Merck's would-be Prevnar rival Vaxneuvance

Retrieved on: 2021-07-19 09:33:45

Tags for this article:

Click the tags to see associated articles and topics

FDA okays Merck's would-be Prevnar rival Vaxneuvance. View article details on hiswai:

Excerpt

Merck's Vaxneuvance – formerly known as V114 – is the first major competition to Pfizer's franchise in the big market for conjugate pneumococcal ...

Article found on: pharmaphorum.com